[go: up one dir, main page]

Smissman et al., 1973 - Google Patents

Conformational study of phenethylamine receptor sites. 2. Synthesis of dl-2-amino-3-phenyl-trans-decalins and dl-2-isopropylamino-3-phenyl-trans-decalins

Smissman et al., 1973

Document ID
13389195395698668035
Author
Smissman E
Pazdernik T
Publication year
Publication venue
Journal of Medicinal Chemistry

External Links

Snippet

General Procedure for Preparation of Isopropyl Analogs. The amine salt was converted to the free amine by the use of a strong base ion-exchange column (Amberlite IRA-400) or by adding the amine salt to a saturated NH3-CHC13 solution, filtering the am-monium salt, and …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2101/00—Systems containing only non-condensed rings
    • C07C2101/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2101/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

Similar Documents

Publication Publication Date Title
RU2152930C2 (en) Substituted benzylaminopiperidines and their pharmaceutically acceptable salts, method of treatment and pharmaceutical composition based on thereof
DE19525137C2 (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as intermediates for the preparation of pharmaceutical agents
PT93753B (en) PROCESS FOR THE PREPARATION OF AZABICYLIC COMPOUNDS
DE2458176A1 (en) SUBSTITUTED 1,3-DIHYDROSPIRO SQUARE CLIP ON ISOBENZOFURANE SQUARE CLIP CLOSE
CH655097A5 (en) SUBSTITUTED CYCLOALKAN AMIDES.
DE69806045T2 (en) CYCLIC PIPERIDINYLAMINOMETHYL-TRIFLUOROMETHYL ETHER DERIVATIVES AS SUBSTANCE P-ANTAGONISTS
EP0024382A1 (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
US4320137A (en) Derivatives of perhydro-aza-heterocycles
EP1491531A1 (en) (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative
JP2543690B2 (en) Pharmaceutical composition
PT86160B (en) PROCESS FOR THE PREPARATION OF MONOCYCLIC, BICYLIC AND TRICYCLIC AMINO ACIDS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION
Smissman et al. Conformational study of phenethylamine receptor sites. 2. Synthesis of dl-2-amino-3-phenyl-trans-decalins and dl-2-isopropylamino-3-phenyl-trans-decalins
US4323575A (en) 1-Phenyl-2-aminoethanol derivatives
Gessner et al. Probes for a Regulatory Site on the Nicotinic Acetylcholine Receptor‐Channel. Synthesis of (±)‐7‐Debutylperhydrohistrionicotoxin,(±)‐2‐Depentyl‐7‐debutylperhydrohistrionicotoxin, and their Analogues
PT87219B (en) PROCESS FOR THE PREPARATION OF SULFONILDECA-HYDRO-8H-ISOKIN (2,1-G} {1,6} NAPHTYRIDINES, OF THEIR OPTICAL ISOMERS AND RELATED COMPOUNDS
US4593037A (en) 1,3-disubstituted piperidine compounds as neuroleptic agents
Smissman et al. Conformational study of phenethylamine receptor sites. 1. Syntheses of semirigid analogs of. beta.-methylamphetamine
Bell et al. Stereochemical studies on medicinal agents. 15. Absolute configurations and analgetic potecies of enantiomeric diastereomers of 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine
Krow et al. Heterodienophiles. 10. Stereoselectivity in the 1, 4-cycloaddition of N-(ethoxycarbonyl)-C-alkylaldiminium ions with 1, 3-cyclohexadiene
EP0139921B1 (en) 2-phenylethylamine derivatives
US4044132A (en) Substituted piperazine derivative, its preparation and anorexia compositions containing it
JPS60258175A (en) Analgesic omega-(hydroxy-, ether and ester)-alkyl-2-amino- cycloalkyl and cycloalkenylamides
US4769373A (en) Anti-arrhythmic azabicyclic compounds
US4291059A (en) Cycloaliphatic compounds, analgesic compositions thereof and method of use thereof as analgesics
HU191337B (en) Process for producing new 4-/2-hydroxy-4-substituted-phenyl/-naphtalene-2/1h/-one and -ol derivatives and pharmaceutical compositions containing them